Vontobel Holding’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-119,000
Closed -$6.05M 1403
2025
Q4
$6.05M Buy
119,000
+12,400
+12% +$634K 0.02% 354
2025
Q3
$5.92M Buy
106,600
+14,600
+16% +$855K 0.02% 350
2025
Q2
$6.35M Buy
+92,000
New +$6.26M 0.02% 327

Other funds holding NVO

Vontobel Holding's NVO Position: Q1 2026 in Review

Vontobel Holding increased its Novo Nordisk (NVO) stake by 65% in Q1 2026, buying an estimated $5.4M and bringing the position to 290,222 shares worth $10.7M. The position accounts for 0.04% of the portfolio, ranked #262.

Vontobel Holding first reported a position in NVO in Q2 2022 and has held it in 11 quarters since. The position peaked at $22.6M in Q4 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Vontobel Holding held 290,222 shares of Novo Nordisk worth $10.7M as of Q1 2026.
  • Vontobel Holding bought 114,071 Novo Nordisk shares in Q1 2026, an estimated $5.4M.
  • Novo Nordisk made up 0.04% of Vontobel Holding's portfolio in Q1 2026, its #262 holding.
  • Vontobel Holding first reported a position in Novo Nordisk in Q2 2022 and has held it in 11 quarters since.
  • Vontobel Holding's Novo Nordisk position peaked at $22.6M in Q4 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Vontobel Holding's 13F filing for Q1 2026, filed 8 May 2026.